Latest News & Updates

Breaking News

  • 1 hour ago

  • Simantini Singh Deo

Outlook Therapeutics Partners With Mediconsult AG For Exclusive Swiss Distribution Of LYTENAVA™ (Bevacizumab Gamma) In Retina Disease Treatment
Breaking News
ImmunityBio Partners With Accord Healthcare To Expand ANKTIVA Access Across Europe Also Establishes Irish Subsidiary

Vaibhavi M.

AtaiBeckley Appoints Michael Faerm As CFO To Lead Financial Strategy As BPL-003 Advances Toward Phase 3, Anne Johnson Becomes Chief Accounting Officer

Simantini Singh Deo

Zenyaku And Chugai Secure Japan’s MHLW Approval Of Rituxan For Autoimmune Hemolytic Anaemia In Public Knowledge-Based Expansion

Vaibhavi M.

Artiva Biotherapeutics Appoints Elaine Sorg To Board To Guide AlloNK Development For Autoimmune Diseases And Rheumatoid Arthritis

Simantini Singh Deo

Other trending news you may like to read

Outlook Therapeutics Partners With Mediconsult AG For Exclusive Swiss Distribution Of LYTENAVA™ (Bevacizumab Gamma) In Retina Disease Treatment

Outlook Therapeutics partners with Mediconsult for exclusive Swiss distribution of LYTENAVA™.

Simantini Singh Deo

Pharma Now

ImmunityBio Partners With Accord Healthcare To Expand ANKTIVA Access Across Europe Also Establishes Irish Subsidiary

ImmunityBio partners with Accord to expand ANKTIVA access across Europe and establishes Irish subsidiary.

Vaibhavi M.

Pharma Now

AtaiBeckley Appoints Michael Faerm As CFO To Lead Financial Strategy As BPL-003 Advances Toward Phase 3, Anne Johnson Becomes Chief Accounting Officer

AtaiBeckley appoints Michael Faerm CFO as BPL-003 advances toward Phase 3; Anne Johnson becomes CAO.

Simantini Singh Deo

Pharma Now

Zenyaku And Chugai Secure Japan’s MHLW Approval Of Rituxan For Autoimmune Hemolytic Anaemia In Public Knowledge-Based Expansion

Zenyaku and Chugai gain Japan MHLW approval to expand Rituxan use to autoimmune hemolytic anaemia.

Vaibhavi M.

Pharma Now